Chronic Myeloproliferative Disorders

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (fenretinide)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • Los Angeles, California
  • +3 more
Jul 18, 2017

Chronic Myeloproliferative Disorders

Completed
  • Polycythemia Vera
  • +4 more
    • Washington, D.C., District of Columbia
    • +1 more
    Jun 30, 2017

    Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

    Completed
    • Chronic Myeloproliferative Disorders
    • +4 more
    • ruxolitinib phosphate
    • +2 more
    • Birmingham, Alabama
    • +23 more
    Oct 22, 2014

    Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial run by the NHLBI

    Terminated
    • Chronic Myeloproliferative Disorders
    • +2 more
    • Bethesda, Maryland
      NIH - Warren Grant Magnuson Clinical Center
    Apr 30, 2013

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (tanespimycin)

    Completed
    • Chronic Myeloproliferative Disorders
    • +4 more
    • Bethesda, Maryland
    • +1 more
    Mar 14, 2012

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (biological, drug, procedure)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • filgrastim
    • +12 more
    • Bethesda, Maryland
      Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
    Mar 7, 2012

    Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial run by the CC (ravuconazole)

    Completed
    • Breast Cancer
    • +11 more
    • Bethesda, Maryland
      Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
    Mar 7, 2012